No Data
No Data
Has Jim Cramer Lost Faith in Biogen Inc. (BIIB)'s Struggles With Alzheimer's and MS Challenges?
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Biogen Price Target Cut to $220.00/Share From $302.00 by Truist Securities
Biogen Is Maintained at Buy by Truist Securities
Biogen Analyst Ratings
102124711 : .
Optanie Numa Marc : PLTR is my prediction.
Salini : PLTR
72377867 Jaddy : NDAQ
105251507 : plntr will add..maybe 1 bitcoin company like microstrategy
View more comments...